NFKB1 and familial pancreatic carcinoma: Liraglutide has been shown to regulate the NF-κB signaling pathway and down-regulate ATP-binding cassette subfamily G member 2, and through these mechanisms to exert pro-apoptotic effects in gemcitabine-resistant pancreatic cancer cells [79].